Ot Lee Methods Year 12 Pdf

[Samantha Figueredo]

Thankyou for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The year 2022 will be remembered as the turning point for accurate long-read sequencing, which now establishes the gold standard for speed and accuracy at competitive costs. We discuss the key bioinformatics techniques needed to power long reads across application areas and close with our vision for long-read sequencing over the coming years.

Advances in long-read sequencing technologies have broadened our understanding of genetic variation in the human population, uncovered new complex structural variants and offered an opportunity to elucidate new variant associations with disease.

Long-read sequencing has become a widely employed technology that enables a comprehensive view of RNA transcripts. Here, we discuss the importance of long-read sequencing in interpreting the variables along RNA molecules, such as polyadenylation sites, transcription start sites, splice sites and other RNA modifications. In addition, we highlight the history of short-read and long-read technologies and their advantages and disadvantages, as well as future directions in the field.

As long-read sequencing technologies continue to advance, the possibility of obtaining maps of DNA and RNA modifications at single-molecule resolution has become a reality. Here we highlight the opportunities and challenges posed by the use of long-read sequencing technologies to study epigenetic and epitranscriptomic marks and how this will affect the way in which we approach the study of health and disease states.

Long-read sequencing has made closed microbial genomes a routine task, and the dramatic increase in quality and quantity now paves the way to a complete microbial tree of life through genome-centric metagenomics.

Pioneering methods in this space have successfully recapitulated key embryonic stages in vitro and thus reshaped our understanding of development. For example, two landmark papers1,2 in 2021 reported in vitro models of the human blastocyst, which is an early preimplantation developmental stage. Earlier this year a team reported3 a human perigastrulation model that recapitulates key events such as the formation of the amniotic and yolk sac cavities, early neurulation and organogenesis.

These models were further refined by incorporating extraembryonic tissues to study postimplantation events. For instance, two studies4,5 published in 2023 reported human stem cell-derived embryo models that could recapitulate embryonic events up to day 14 postimplantation in vivo.

These methods for modeling human development follows on the heels of technological advances and achievements first reported in mouse studies. Two seminal papers6,7 described in vitro models derived from mouse stem cells that could recapitulate natural mouse embryos in utero up to 8.5 days postfertilization. These embryos developed until the organogenesis stage, co-developing with extraembryonic tissues. The complexity of this model, which mimicked natural embryos in morphological and transcriptomic analysis, led to more authentic organ and tissue development. However, while conclusions can be drawn from studying developmental processes in animal models, species specific features of human embryonic development can be easily missed in such cases.

In this special issue, a Comment8 by Magdalena Zernicka-Goetz provides an in-depth look at the latest embryo models that have been reported. These models are poised to help researchers to investigate the molecular mechanisms behind morphogenesis and the signaling cues that underlie the tissue patterning. Zernicka-Goetz warns researchers that while these embryo models lead to novel insights, they are far from perfect recapitulations of the in vivo embryo. Indeed, it is imperative to be aware of the limitations of a system and how it might affect the inferences that are drawn.

The fidelity of an in vitro model must always be verified against in vivo-derived tissue. In the case of embryonic tissue, this poses a particular challenge due to the limited availability of embryos for research as well as ethical issues surrounding human embryo manipulations. A Comment9 by Muzlifah Haniffa and colleagues discusses how the advent of single-cell multiomic technologies and the subsequent developmental cell atlases have served as essential benchmarks for testing the validity of an embryo model.

Beyond the development of cell atlases, single-cell technologies have also led to the emergence of sophisticated methods for lineage tracing and trajectory analysis. Although these methods have not yet been extensively used for human embryonic models, they have been instrumental in mapping cell fate events, such as in human brain organoids10 and zebrafish embryos11. In a Comment12, Bushra Raj describes recent methodological advances in this field and its potential for studying snapshots of development.

The state-of-the-art embryo models have been bolstered by decades of research into methods for the in vitro culture of mammalian embryos. Hongmei Wang and colleagues explore this in their Comment13. They write that to optimize culture conditions that support an in vitro embryo, there is still a need for the development of biomaterials that mimic the physiological microenvironment of the embryos, as well methods to study the mechanical environment experienced by cells during the stages of embryogenesis.

This opinion is echoed by Idse Heemskerk and colleagues in another Comment14, which discusses recent methods that now allow researchers to map the forces within a developing embryo. The Comment explores how embryo models have the potential to shed light on the interplay between tissue mechanics, patterning and morphogenesis. Related to this, a research paper in this same issue from Herv Turlier and colleagues reports foambryo15, a method for performing force inference from 3D fluorescence images of mouse and ascidian embryos. A second research paper, by Noah Mitchell and Dillon Cislo, presents TubULAR16, a tissue cartography method for analyzing deformations in dynamic tissues during processes such as morphogenesis.

A nascent approach to studying embryonic development is computational embryology. Researchers explore how to computationally generate and perturb virtual embryos that are built from experimental data. A research article17 from the team of Patrick Mller describes a deep learning-based approach to grade the similarities between embryos at different time points. In an earlier issue of Nature Methods, the same team published EmbryoNet18, a neural network that can analyze zebrafish embryo phenotypes and link them to major signaling pathways. Our News Feature19 also checks in with researchers in this area, who share hopes and challenges concerning digital embryos and their future.

In a discussion about advances in embryo research, it would be remiss to not consider the ethical implications of engineering human embryo models. In their Comment20, ethicists Nienke de Graeff, Lien De Proost and Megan Munsie explain the new ethical questions posed by embryo models. They discuss whether embryo models should be held to the same guidelines as organoids or whether their developmental potential affords them a new status.

Embryo models, especially human systems, are a new and exciting frontier supported by parallel methods development in the fields of single-cell omics, biomaterials and mechanobiology. We must have an open and transparent dialog about the limitations of these methods as well as the ethical risks of in vitro human embryos models. Meanwhile, we hope you are with us as we recognize the potential these methods have in not only unraveling the details of embryogenesis but also modeling development and pregnancy-related disorders.

This June, we published a special issue highlighting the success of the Telomere-to-Telomere (T2T) Consortium in presenting the first complete human genome. This achievement was made possible by a wide range of experimental and computational efforts. Among them was long-read sequencing, the main sequencing technology responsible for generating the T2T data, which arguably laid the foundation of this feat. Yet the work from the T2T Consortium is only one example of the vast number of discoveries long-read sequencing is enabling in reading genomes, transcriptomes and epigenomes in humans and other species. For its momentous methodological advancement and broad application, we have chosen long-read sequencing as our Method of the Year 2022.

As in many other fields where new technologies are emerging, computational methods are vital role to translating the rich information embedded in long-read sequences to biological discoveries. A Comment from Michael Schatz and colleagues highlights such developments. Active method development is ongoing for many long-read data analysis tasks, ranging from identifying different bases and chemical modifications in DNA and RNA to genome assembly and genome variation detection. One promising direction is to apply advanced statistical and machine learning methods, which have shown remarkable performance in other fields for many computationally challenging tasks. They are increasingly becoming the core elements of the toolbox for long-read data analysis, and we expect the trend to continue into the future.

3a8082e126